COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Molecular Interactions
Last updated: 2024 Apr 18
Total hit(s): 5180
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
Auto summary
Ascending order
Descending order
1
38361363
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38512394
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38304547
Binding affinity between coronavirus spike protein and human ACE2 receptor.
Comput Struct Biotechnol J
2024 Dec
5.11
1
4
38550333
Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis.
Saudi Pharm J
2024 May
5.6
1
5
38599653
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.
RMD Open
2024 Apr 9
6.1
1
6
38589848
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Virol J
2024 Apr 9
2.45
1
7
38592189
Prediction of deleterious non-synonymous SNPs of TMPRSS2 protein combined with Molecular Dynamics Simulations and free energy analysis to identify the potential peptide substrates against SARS-CoV-2.
J Biomol Struct Dyn
2024 Apr 9
3.22
1
8
38591877
Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
J Virol
2024 Apr 9
4.16
1
9
38593595
Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
Virology
2024 Apr 8
2.819
1
10
38581432
What is the economic benefit of annual COVID-19 vaccination from the adult individual perspective?
J Infect Dis
2024 Apr 6
4.73
1
11
38576396
Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of omicron (B1.1.529) pseudovirus.
Virulence
2024 Apr 5
4.81
1
12
38497901
Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2.
Chem Commun (Camb)
2024 Apr 4
10.1
1
13
38608595
In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.
Phytomedicine
2024 Apr 4
7.2
1
14
38573524
Specific features of epitope-MIPs and whole-protein MIPs as illustrated for AFP and RBD of SARS-CoV-2.
Mikrochim Acta
2024 Apr 4
10.1
1
15
38617283
Predicting Functional Conformational Ensembles and Binding Mechanisms of Convergent Evolution for SARS-CoV-2 Spike Omicron Variants Using AlphaFold2 Sequence Scanning Adaptations and Molecular Dynamics Simulations.
bioRxiv
2024 Apr 3
- n/a -
1
16
38570577
Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco.
Sci Rep
2024 Apr 3
4.12
1
17
38570605
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.
Commun Med (Lond)
2024 Apr 3
1
18
38575433
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial.
Vaccine
2024 Apr 3
3.31
1
19
38564431
Self-Assembling Sulfated Lactobacillus Exopolysaccharide Nanoparticles as Adjuvants for SARS-CoV-2 Subunit Vaccine Elicit Potent Humoral and Cellular Immune Responses.
ACS Appl Mater Interfaces
2024 Apr 2
14.4
1
20
38565881
SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand.
Sci Rep
2024 Apr 2
4.12
1
21
38617221
Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance.
bioRxiv
2024 Apr 2
- n/a -
1
22
38631949
Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.
Vaccine
2024 Apr 17
3.31
1
23
38632526
The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis.
Mol Med
2024 Apr 17
6.9
1
24
38624015
A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus.
Cytometry A
2024 Apr 16
3.69
1
25
38597182
Enteric coronavirus nsp2 is a virulence determinant that recruits NBR1 for autophagic targeting of TBK1 to diminish the innate immune response.
Autophagy
2024 Apr 16
10.79
1